Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Shattuck Labs (STTK) EBT (2019 - 2025)

Shattuck Labs (STTK) has disclosed EBT for 7 consecutive years, with -$13.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 31.92% to -$13.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$51.5 million, a 36.07% increase, with the full-year FY2025 number at -$48.8 million, up 35.27% from a year prior.
  • EBT was -$13.4 million for Q4 2025 at Shattuck Labs, down from -$10.7 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $7.9 million in Q4 2021 to a low of -$28.6 million in Q3 2023.
  • A 5-year average of -$18.6 million and a median of -$19.8 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: skyrocketed 166.39% in 2021, then plummeted 431.6% in 2022.
  • Shattuck Labs' EBT stood at $7.9 million in 2021, then tumbled by 431.6% to -$26.3 million in 2022, then increased by 27.88% to -$19.0 million in 2023, then dropped by 3.64% to -$19.6 million in 2024, then soared by 31.92% to -$13.4 million in 2025.
  • Per Business Quant, the three most recent readings for STTK's EBT are -$13.4 million (Q4 2025), -$10.7 million (Q3 2025), and -$13.0 million (Q2 2025).